Investigative Clinical Study for Diabetes Rev A

• Research type

  Research Study

• Full title

  COLLECTION OF VENOUS AND CAPILLARY BLOOD SAMPLES FOR THE DEVELOPMENT OF NEW DIAGNOSTIC DEVICES FOR THE PREVENTION, MONITORING AND MANAGEMENT OF DIABETES.

• IRAS ID

  179249

• Contact name

  Humaira Qayyum

• Contact email

  Humaira.Qayyum@mst-uk.com

• Sponsor organisation

  Multi-Sense Technologies Ltd

• Duration of Study in the UK

  5 years, 0 months, 0 days

• Research summary

  MST are developing a range of biomarker tests for the management of diabetes. The purpose of this study is to support the development of a new generation of point-of-care diagnostic devices that can substantially enhance clinicians’ and patients’ ability to diagnose, monitor and manage a range of acute and chronic health conditions.

  These devices have the potential to improve patient outcomes and reduce the cost of care for large numbers of people. Venous and capillary blood samples collected from participants will be used to develop new products and platforms for measuring biomarkers including, but not limited to,
  Glucose, C-Peptide ,Calcium, Pro-Insulin, Endogenous Insulin , Insulin Analogues , Maltose, Ketones , Xylose, Coagulation, HbA1c, Potassium, Creatinine, TSH , T4 (free Thyroxine), Uric Acid, Ascorbic Acid, CRP, Sodium , Chlorine, Iron, Urea, Total protein, Albumin, Gamma GT, Bilirubin.

• REC name

  West of Scotland REC 3

• REC reference

  15/WS/0175

• Date of REC Opinion

  30 Sep 2015

• REC opinion

  Further Information Favourable Opinion